These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30703656)

  • 1. Attachment of a 5-nitrofuroyl moiety to spirocyclic piperidines produces non-toxic nitrofurans that are efficacious in vitro against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Sharoyko V; Tennikova TB; Dar'in D; Sokolovich E
    Eur J Med Chem; 2019 Mar; 166():125-135. PubMed ID: 30703656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Nitrofuran-Warhead-Equipped Spirocyclic Azetidines Show Excellent Activity against
    Komarova K; Vinogradova L; Lukin A; Zhuravlev M; Deniskin D; Chudinov M; Gureev M; Dogonadze M; Zabolotnykh N; Vinogradova T; Lavrova A; Yablonskiy P
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New nitrofurans amenable by isocyanide multicomponent chemistry are active against multidrug-resistant and poly-resistant Mycobacterium tuberculosis.
    Krasavin M; Parchinsky V; Kantin G; Manicheva O; Dogonadze M; Vinogradova T; Karge B; Brönstrup M
    Bioorg Med Chem; 2017 Mar; 25(6):1867-1874. PubMed ID: 28214232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents.
    Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y
    Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of N-benzyl-5-nitrofuran-2-carboxamide as an antitubercular agent.
    Gallardo-Macias R; Kumar P; Jaskowski M; Richmann T; Shrestha R; Russo R; Singleton E; Zimmerman MD; Ho HP; Dartois V; Connell N; Alland D; Freundlich JS
    Bioorg Med Chem Lett; 2019 Feb; 29(4):601-606. PubMed ID: 30600207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents.
    Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Wang D; Qin X; Jiang B; Wu W; Liu M; Lu Y
    Bioorg Med Chem; 2022 Jan; 53():116529. PubMed ID: 34861474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current development of 5-nitrofuran-2-yl derivatives as antitubercular agents.
    Elsaman T; Mohamed MS; Mohamed MA
    Bioorg Chem; 2019 Jul; 88():102969. PubMed ID: 31077910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
    Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
    Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship studies on 3,5-dinitrophenyl tetrazoles as antitubercular agents.
    Němeček J; Sychra P; Macháček M; Benková M; Karabanovich G; Konečná K; Kavková V; Stolaříková J; Hrabálek A; Vávrová K; Soukup O; Roh J; Klimešová V
    Eur J Med Chem; 2017 Apr; 130():419-432. PubMed ID: 28279848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentacyclic nitrofurans with in vivo efficacy and activity against nonreplicating Mycobacterium tuberculosis.
    Rakesh ; Bruhn DF; Scherman MS; Woolhiser LK; Madhura DB; Maddox MM; Singh AP; Lee RB; Hurdle JG; McNeil MR; Lenaerts AJ; Meibohm B; Lee RE
    PLoS One; 2014; 9(2):e87909. PubMed ID: 24505329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel 2-aminothiazole conjugated nitrofuran as antitubercular and antibacterial agents.
    Ran K; Gao C; Deng H; Lei Q; You X; Wang N; Shi Y; Liu Z; Wei W; Peng C; Xiong L; Xiao K; Yu L
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3669-74. PubMed ID: 27289321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing of a drug scaffold: Identification of novel sila analogues of rimonabant as potent antitubercular agents.
    Ramesh R; Shingare RD; Kumar V; Anand A; B S; Veeraraghavan S; Viswanadha S; Ummanni R; Gokhale R; Srinivasa Reddy D
    Eur J Med Chem; 2016 Oct; 122():723-730. PubMed ID: 27476117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical, pharmacokinetic, efficacy and toxicity profiling of a potential nitrofuranyl methyl piperazine derivative IIIM-MCD-211 for oral tuberculosis therapy via in-silico-in-vitro-in-vivo approach.
    Magotra A; Sharma A; Singh S; Ojha PK; Kumar S; Bokolia N; Wazir P; Sharma S; Khan IA; Singh PP; Vishwakarma RA; Singh G; Nandi U
    Pulm Pharmacol Ther; 2018 Feb; 48():151-160. PubMed ID: 29174840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bis-spirochromanones as potent inhibitors of Mycobacterium tuberculosis: synthesis and biological evaluation.
    Dongamanti A; Aamate VK; Devulapally MG; Gundu S; Balabadra S; Manga V; Yogeeswari P; Sriram D; Balasubramanian S
    Mol Divers; 2017 Nov; 21(4):999-1010. PubMed ID: 28840414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
    Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
    Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agents.
    Courtens C; Risseeuw M; Caljon G; Maes L; Cos P; Martin A; Van Calenbergh S
    Bioorg Med Chem Lett; 2019 May; 29(10):1232-1235. PubMed ID: 30879839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
    Chopra S; Koolpe GA; Tambo-Ong AA; Matsuyama KN; Ryan KJ; Tran TB; Doppalapudi RS; Riccio ES; Iyer LV; Green CE; Wan B; Franzblau SG; Madrid PB
    J Med Chem; 2012 Jul; 55(13):6047-60. PubMed ID: 22691154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of novel dispirooxindolopyrrolidine and dispirooxindolopyrrolothiazole derivatives as potential antitubercular agents.
    Mhiri C; Boudriga S; Askri M; Knorr M; Sriram D; Yogeeswari P; Nana F; Golz C; Strohmann C
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4308-13. PubMed ID: 26271585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.